ADR120S, Inc. (TYO:3750)

Japan flag Japan · Delayed Price · Currency is JPY
913.00
+8.00 (0.88%)
Aug 14, 2025, 3:30 PM JST
0.88%
Market Cap8.15B
Revenue (ttm)122.00M
Net Income (ttm)-2.14B
Shares Out8.93M
EPS (ttm)-239.69
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,900
Average Volume3,750
Open913.00
Previous Close913.00
Day's Range913.00 - 921.00
52-Week Range642.00 - 990.00
Beta0.07
RSI60.41
Earnings DateAug 14, 2025

About Achilles Therapeutics

ADR120S, Inc. engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence and liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases and applications, inclu... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 10
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 3750
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.